13+ hour, 20+ min ago  (213+ words) ROCKVILLE, Md. --(BUSINESS WIRE)--Leadiant Biosciences, Inc. today announced that Health Canada has approved Cysklar" (cysteamine ophthalmic solution) 0. 44%, a topical eye drop solution indicated for the treatment of corneal cystine crystal accumulation in people with cystinosis. Cystinosis is a rare but…...

1+ week, 6+ day ago  (294+ words) MIDDLETON, Wis. , April 1, 2026 /PRNewswire/ -- Imbed Biosciences today announced that the Centers for Medicare & Medicaid Services (CMS) has assigned a Healthcare Common Procedure Coding System (HCPCS) Level II code, A2040, to Microlyte" Pain Guard", the company's synthetic wound matrix incorporating silver for…...

1+ week, 6+ day ago  (337+ words) Novel Transdermal Curcumin Formulation Demonstrates Pain Reduction and Improved Quality of Life in Phase 1b Clinical Trial Study published in Frontiers in Pain Research reports significant reduction in knee pain with topical curcumin formulation The clinical trial demonstrated that participants using…...

1+ mon, 5+ day ago  (292+ words) Milestone marks entry into Limited Market Release and builds momentum toward broader commercialization NEW YORK--(BUSINESS WIRE)--VB Spine LLC (VB Spine), today announced the successful completion of the first clinical cases utilizing the Vulcan" Spinal System for thoracolumbar fixation....

1+ mon, 1+ week ago  (508+ words) Bio Space Kallyope to Present Phase 2b Study Results for Elismetrep for the Acute Treatment of Migraine at the 2026 American Academy of Neurology Annual Meeting - March 5, 2026 Clinically meaningful data establishes proof of concept for elismetrep as a promising therapeutic candidate for…...

1+ mon, 1+ week ago  (282+ words) -Over 90% of patients in the study were opioid free through the end of multimodal treatment with JOURNAVX- -These data have been accepted for oral presentation at the American Academy of Pain Medicine Meeting- JOURNAVX was generally safe and well tolerated…...

1+ mon, 1+ week ago  (184+ words) PLANO, Texas, March 5, 2026 /PRNewswire/ -- ulrich medical USA is pleased to announce the appointment of'Alissa Calaway, RN, MSN, as Director of U. S. Clinical Affairs. Alongside'this leadership appointment, the company is launching a U. S. -based Clinical Research Program'designed to generate clinical evidence supporting product…...

1+ mon, 1+ week ago  (547+ words) NEW ORLEANS--(BUSINESS WIRE)--At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery (HSS) presented several significant studies, two of which could lead to changes in how surgeons counsel families of young…...

1+ mon, 1+ week ago  (222+ words) The final study, "Cefazolin and the R-1 Side Chain: Why Your Joint Arthroplasty Patients With Cephalosporin Allergy Can Safely Be Given Cefazolin," assessed the safety and effectiveness of the antibiotic Cefazolin in patients with documented cephalosporin allergies. This is the first…...

1+ mon, 2+ week ago  (582+ words) This needs to change'both to help curb the opioid crisis and to meet the needs of the millions of patients suffering in pain. Often opioids are the only effective treatment for moderate to severe pain, yet they fuel a public…...